Cytosine residues influence kidney accumulations of 99mTc-labeled morpholino oligomers

Antisense and Nucleic Acid Drug Development

Volumn 12, Issue 6, 2002, Pages 393-398

  Liu, Guozheng ^a   He, Jiang ^a   Zhang, Surong ^a   Liu, Changbin ^a   Rusckowski, Mary ^a   Hnatowich, Donald J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; MERTIATIDE TC 99M; MORPHOLINO OLIGOMER; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; OLIGOMER; PHOSPHOROTHIOATE DNA; THYMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BASE PAIRING; CANCER CELL; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BINDING; DRUG CLEARANCE; DRUG CONJUGATION; DRUG DEGRADATION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG STRUCTURE; DRUG TRANSPORT; DRUG URINE LEVEL; IN VIVO STUDY; ISOTOPE LABELING; KIDNEY CLEARANCE; LIVER CLEARANCE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANIMALIA;

EID: 0036973187     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729002321082465     Document Type: Article

References (13)

1. AGRAWAL, S., TEMSAMANI, J., and TANG, J.Y. (1991). Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice. Proc. Natl. Acad. Sci. USA 88, 7595-7599.
2. 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats. J. Pharmacol. Exp. Ther. 267, 1181-1190.
3. DELONG, R.K., NOLTING, A., FISHER, M., CHEN, Q., WICKSTROM, E., KLIGSHTEYN, M., DEMIRDJI, S., CARUTHERS, M., and JULIANO, R.L. (1997). Comparative pharmacokinetics, tissue distribution, and tumor accumulation of phosphorothioate, phosphorodithioate, and methylphosphonate oligonucleotides in nude mice. Antisense Nucleic Acid Drug Dev. 7, 71-77.
4. GOODAZI, G., WATABE, M., and WATABE, K. (1992). Organ distribution and stability of phosphothioate oligodeoxyribonucleotides in mice. Biopharm. Drug Dispos. 13, 221-227.
5. HNATOWICH, D.J., MARDIROSSIAN, G., FOGARASI, M., SANO, T., SMITH, C.L., CANTOR, C.R., RUSCKOWSKI, M., and WINNARD, P., Jr. (1996). Comparative properties of a technetium-99m-labeled single-stranded natural DNA and a phosphorothioate derivative in vitro and in mice. J. Pharmacol. Exp. Ther. 276, 326-334.
6. LIU, G., MANG'ERA, K., LIU, N., GUPTA, S., RUSCKOWSKI, M., and HNATOWICH, D.J. (2002a). Tumor pretargeting in mice using technetium-99m labeled morpholinos, a DNA analog. J. Nucl. Med. 43, 384-391.
7. 99mTc-morpholinos in mice. Q. J. Nucl. Med. 46, 233-243.
8. 3 conjugated morpholino oligomers. Bioconjugate Chem. 13, 893-897.
9. MANG'ERA, K., LIU, G., ZHANG, Y., LIU, N., GUPTA, S., RUSCKOWSKI, M., and HNATOWICH, D.J. (2001). Initial investigations of morphilinos for radiopharmaceutical applications. Eur. J. Nucl. Med. 28, 1682-1689.
10. RAPPAPORT, J., HANSS, B., KOPP, J.B., COPELAND, T.D., BRUGGEMAN, L.A., COFFMAN, T.M., and KLOTMAN, P.E. (1995). Transport of phosphorothioate oligonucleotides in kidney: Implications for molecular therapy. Kidney Int. 47, 1462-1469.
11. WINNARD, P., Jr., CHANG, F., RUSCKOWSKI, M., MARDIROSSIAN, G., and HNATOWICH, D.J. (1997). Preparation and use of NHS-MAG3 for technetium-99m labeling of DNA. Nucl. Med. Biol. 24, 425-432.
12. 76Br-labeled antisense oligonucleotides of different length determined ex vivo in rats. Eur. J. Pharm. Sci. 10, 179-186.
13. 99mTc-labeled antisense DNA. J. Nucl. Med. 42, 1660-1669.